Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.
Queensland Institute of Medical Research-Berghofer Medical Research Institute, Brisbane, Australia.
Parasit Vectors. 2020 May 11;13(1):240. doi: 10.1186/s13071-020-04091-5.
Humans are the primary hosts of dengue viruses (DENV). However, sylvatic cycles of transmission can occur among non-human primates and human encroachment into forested regions can be a source of emergence of new strains such as the highly divergent and sylvatic strain of DENV2, QML22, recovered from a dengue fever patient returning to Australia from Borneo. The objective of the present study was to evaluate the vector competence of Australian Aedes aegypti mosquitoes for this virus.
Four- to five-day-old mosquitoes from two strains of Ae. aegypti from Queensland, Australia, were fed a meal of sheep blood containing 10 50% cell culture infectious dose per ml (CCID/ml) of either QML22 or an epidemic strain of DENV serotype 2 (QML16) isolated from a dengue fever patient in Australia in 2015. Mosquitoes were maintained at 28 °C, 75% relative humidity and sampled 7, 10 and 14 days post-infection (dpi). Live virions in mosquito bodies (abdomen/thorax), legs and wings and saliva expectorates from individual mosquitoes were quantified using a cell culture enzyme-linked immunosorbent assay (CCELISA) to determine infection, dissemination and transmission rates.
The infection and dissemination rates of the sylvatic DENV2 strain, QML22, were significantly lower than that for QML16. While the titres of virus in the bodies of mosquitoes infected with either of these viruses were similar, titres in legs and wings were significantly lower in mosquitoes infected with QML22 at most time points although they reached similar levels by 14 dpi. QML16 was detected in 16% (n = 25) and 28% (n = 25) of saliva expectorates at 10 and 14 dpi, respectively. In contrast, no virus was detected in the saliva expectorates of QML22 infected mosquitoes.
Australia urban/peri-urban Ae. aegypti species are susceptible to infection by the sylvatic and highly divergent DENV 2 QML22 but replication of QML22 is attenuated relative to the contemporary strain, QML16. A salivary gland infection or escape barrier may be acting to prevent infection of saliva and would prevent onward transmission of this highly divergent virus in Australia.
人类是登革热病毒(DENV)的主要宿主。然而,在非人类灵长类动物中可能存在丛林传播周期,人类侵入森林地区可能是新菌株出现的源头,例如从从婆罗洲返回澳大利亚的登革热患者中分离出的高度分化和丛林型 DENV2 株 QML22。本研究的目的是评估澳大利亚埃及伊蚊对该病毒的媒介能力。
从澳大利亚昆士兰州的两个埃及伊蚊品系中采集 4-5 天大的蚊子,喂食含有 10 50%细胞培养感染剂量/毫升(CCID/ml)的 QML22 或 2015 年澳大利亚登革热患者分离的流行株 DENV 血清型 2(QML16)的绵羊血餐。蚊子在 28°C、75%相对湿度下饲养,并在感染后 7、10 和 14 天进行采样。使用细胞培养酶联免疫吸附试验(CCELISA)定量检测蚊子体内(腹部/胸部)、腿部和翅膀以及单个蚊子唾液中的活病毒,以确定感染、传播和传播率。
丛林型 DENV2 株 QML22 的感染和传播率明显低于 QML16。虽然感染这些病毒的蚊子的病毒滴度相似,但 QML22 感染的蚊子腿部和翅膀的病毒滴度在大多数时间点都明显较低,尽管到 14 dpi 时达到相似水平。在 10 和 14 dpi 时,分别在 16%(n=25)和 28%(n=25)的唾液提取物中检测到 QML16。相比之下,在 QML22 感染的蚊子的唾液提取物中未检测到病毒。
澳大利亚城市/城郊埃及伊蚊种易感染丛林型和高度分化的 DENV 2 QML22,但与当代株 QML16 相比,QML22 的复制能力减弱。唾液腺感染或逃逸屏障可能会阻止感染唾液,并防止这种高度分化的病毒在澳大利亚的传播。